Pretoria, 10 October 2022 – The South African Health Products Regulatory Authority (SAHPRA), like other regulators globally, has been alerted to dubious health products being traded by an Indian company, Maiden Pharmaceuticals. The products as they appear on the World Health Organisation (WHO) product list (Medical...
Pretoria, 07 October 2022 – The South African Health Products Regulatory Authority (SAHPRA) hosted the African Union Development Agency (AUDA-NEPAD) as part of the African Union’s Smart Safety Surveillance (AU-3S) programme. African Union’s Smart Safety Surveillance (AU-3S) programme is aimed at strengthening the safety surveillance of...
Pretoria, 06 October 2022 – The South African Health Products Regulatory Authority (SAHPRA), as part of its awareness campaign targeting tertiary institutions, visited the University of the Witwatersrand (Wits) on Thursday, the 6th of October. Human Resources (HR) and the Inspectorate and Regulatory Compliance unit...
Pretoria, 5 October 2022 - The South African Health Products Regulatory Authority (SAHPRA) has recently been ranked by the World Health Organisation (WHO) at a functional level of maturity (Level 3) according to WHO’s global classification system for national medical products regulatory authorities. This means...
UPDATE ON COVID-19 HEALTH PRODUCTS: SAHPRA registers the Covovax COVID-19 vaccine from Cipla (Pty) Ltd and additional indication of use of COVID-19 vaccine MC Pharma from MC Pharma (Pty) Ltd in the age group 3 -17 years. Pretoria, 28 September 2022 – SAHPRA registered a COVID-19...
SAHPRA invited all local and foreign Conformity assessment bodies to a joint meeting with SANAS. The session is scheduled as follows: Download Agenda Recording below: ...
In commemoration of World Patient Safety Day and World Pharmacist Day (observed annually on 17 and 25 September, respectively), the South African Health Products Regulatory Authority (SAHPRA) hosted a Medicine Safety Webinar on 26 September 2022. The webinar focused on increasing awareness and reporting of adverse...
Patient safety resonates with SAHPRA’s mission of ensuring that the public is protected by registering and regulating all health products so that they comply with SAHPRA’s pillars of safety, quality, efficacy and performance. This involves ensuring that stringent regulatory requirements are followed before any health product is made...
Pretoria, 12 September 2022 - On the 04th of August 2022, SAHPRA issued a media statement relating to the first fatal case of GBS following vaccination with COVID-19 Vaccine Janssen. Recently, SAHPRA has been informed of a second fatal case of Guillain-Barré syndrome (GBS) following...
KwaZulu-Natal, 12 September 2022 – SAHPRA is planning on visiting universities that offer studies relating to pharmacy and medicines. These visits will create an awareness about SAHPRA to students. Its mandate and its roles and responsibilities include educating the students about the Authority’s programmes. There will...
